Terminating clinical trials without sufficient subjects

Journal of Medical Ethics

Volumn 38, Issue 7, 2012, Pages 413-416

  Damen, Lianne ^a   van Agt, Frans ^a   de Boo, Theo ^a   Huysmans, Frans ^a  

^a Research Ethics Committee   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL TRIAL (TOPIC); ETHICS; HUMAN; MEDICAL RESEARCH; METHODOLOGY; PATIENT SELECTION; RESEARCH SUBJECT; STANDARD; STATISTICS;

BIOMEDICAL RESEARCH; CLINICAL TRIALS AS TOPIC; HUMANS; PATIENT SELECTION; RESEARCH DESIGN; RESEARCH SUBJECTS;

EID: 84864004729     PISSN: 03066800     EISSN: 14734257     Source Type: Journal    
DOI: 10.1136/medethics-2011-100020     Document Type: Article

References (22)

1. Emanuel EJ, Wendler D, Grady C. What makes clinical research ethical? JAMA 2000;283:2701e11.
2. National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research. The Belmont Report. National Institutes of Health, Department of Health, Education, and Welfare, 1974.
3. Levine RJ. Ethics and Regulation of Clinical Research. 2nd edn. New Haven and London: Yale University Press, 1988.
4. Dutch Medical Research with Human Subjects Law (WMO). 1999.
5. Gorringe JAL. Initial preparation for clinical trials. In: Harris EL, Fitzgerald JD, eds. The Principals and Practice of Clinical Trials. Edinburgh, London: Livingstone, 1970.
6. Wouden van der JC, Blankenstein AH, Huibers MJH, et al. Survey among 78 studies showed that Lasagna's law holds in Dutch primary care research. J Clin Epidemiol 2007;60:819e24.
7. Unger S, Wylie L, Fallah S, et al. Motivated by Money? The impact of financial Incentive for the research Team on study recruitment. IRB 2010;32:16e19.
8. McDonald AM, Knight RC, Campbell MK, et al. What influences recruitment to randomized controlled trials? A review of trials funded by two UK finding agencies. Trials 2006;7:9.
9. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. Guidelines for Good Clinical Practice. 1997.
10. Edwards SJ, Kirchin S, Huxtable R. Research ethics committees and paternalism. J Med Ethics 2004;30:88e91.
11. Garrard E, Dawson A. What is the role of the research ethics committee? Paternalism, inducement, and harm in research ethics. J Med Ethics 2005;31:419e23.
12. Mann H. Research ethics committees and public dissemination of clinical trial results. Lancet 2002;359:406e8.
13. Gibson LM, Brazzelli M, Thomas BM, et al. A systematic review of clinical trials of pharmacological interventions for acute ischaemic stroke (1955-2008) that were completed, but not published full. Trials 2010;11:43.
14. Pich J, Carne ́ X, Arnaiz JA, et al. Role of a research ethics committee in follow-up and publication of results. Lancet 2003;361:1015e16.
15. WMA Declaration of HelsinkidEthical Principles for Medical Research Involving Human Subjects 59th WMO General Assembly. Seoul: 2008.
16. Antes G, Chalmers I. Under-reporting of clinical trials is unethical. Lancet 2003;361:978e9.
17. Viergever RF, Ghersi D. The quality of Registration of clinical trials. PLoS ONE 2011 6:e14701.
18. Chan A-W, Hróbjartsson A, Jørgensen KJ, et al. Discrepancies in sample size calculations and data analyses reported in randomised trials: comparison of publications with protocols. BMJ 2008;337:a2299.
19. Moher D, Hopewell S, Schulz KF, et al. CONSORT 2010. Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials. BMJ 2010;340:c869.
20. Schulz KF, Altman DG, Moher D. Consort 2010 statement: update guidelines for reporting parallel group randomized trials. Ann Intern Med 2010;152:1e8.
21. Dwan K, Altman DG, Arnaiz JA, et al. Systematic review of the Empirical evidence of study publication Bias and outcome reporting Bias. PLoS ONE 2008;3:e3081.
22. Chalmers I, Glasziou P. Avoidable waste in the production and reporting of research evidence. Lancet 2009;374:86e9.